Skip to content

Exploring the biological mechanism of sleepless "Zhoujing" based on cell energy metabolomics and its verification

Explore the biological mechanism of sleepless "day sperm" based on cell energy metabolomics and its verification

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071765
Enrollment
Unknown
Registered
2023-05-24
Start date
2023-04-22
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia disorder

Interventions

Experimental group (Intervention part):Shuhe Granule
Control group (Intervention part):Placebo
Healthy control group (Cross-sectional part):No
"zhoujing" insomnia group (Cross-sectional part):No
"non-zhoujing" insomnia group (Cross-sectional part):No

Sponsors

Guangdong Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. For insomnia disorder: (1) 18-70 years old; (2) In line with the Western diagnostic criteria for insomnia disorders; (3) Total score of PSQI > 7; (4) Sign informed consent; 2. Healthy control group: (1) 18-70 years old; (2) No complaints of insomnia; (3) Total score of PSQI < 7; (4) Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. For insomnia disorder: (1) Based on the history and consultation, the doctor confirms secondary insomnia caused by another disease. For example: local pain, restless leg syndrome, moderate to severe sleep apnea syndrome, acute and chronic heart failure, chronic obstructive pulmonary disease, acute and chronic bronchitis; (2) Complicated with serious and unstable diseases of cardiovascular, cerebrovascular, lung, liver, kidney and endocrine system; (3) Patients with anxiety disorder, depression disorder, bipolar disorder, schizophrenia, post-traumatic stress disorder and other mental disorders affecting sleep (using DSM-5 based self-compiled interview tools); (4) Weekly high-intensity exercise (do 4 to 6 times, 30-second high-intensity sprints with certain difficulty, rest for 4 minutes at each interval, and train for 3 days a week); (5) Taking sedative hypnotic drugs and other psychiatric drugs in the past 2 weeks; (6) Pregnant or lactating women; (7) Other situations not suitable for inclusion in the study. 2. Healthy control group: (1) Meet the diagnostic criteria of any disease in DSM-4; (2) Complicated with serious diseases of cardiovascular, cerebrovascular, lung, liver, kidney and endocrine system; (3) Weekly high-intensity exercise (do 4 to 6 times, 30-second high-intensity sprints with certain difficulty, rest for 4 minutes at each interval, and train for 3 days a week); (4) Regular use of sedative hypnotic drugs and other psychiatric drugs in the past two weeks; (5) Pregnant or lactating women; (6) Other situations not suitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Energy metabolomics;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index Scale;Montreal Cognitive Assessment;Fatigue severity scale;Generalized Anxiety Scale-7;Insomnia Severity Index;

Countries

China

Contacts

Public ContactZhimin Yang

Guangdong Provincial Hospital of TCM

yangyo@vip.tom.com+86 20 8149 9399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026